OBSERVATIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN AN ULCERATIVE COLITIS POPULATION COMPRISED BY BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Francisco Casellas  ¹     Cristina Rodriguez  ²     Javier Pérez Gisbert  ³     Claudia Herrera de Guise  ⁴     Ana Gutiérrez-Casbas  ⁵     Isabel Vera Mendoza  ⁶     Sabino Riestra  ⁷     Pilar Martínez-Montiel  ⁸     María Dolores Martín-Arranz  ⁹     Vanesa Royo  ¹⁰     Patricia Suárez  ¹¹     Orlando Garcia-Bosch  ¹²     Esther García-Planella  ¹³     Marisa Iborra  ¹⁴     Jesus Aparicio  ¹⁵     Alonso Fernandez-Nistal  ¹⁵     Ignacio Tagarro  ¹⁵     Carmen Montoto  ¹⁵     Fernando Muñoz  ^16    
1 Hospital Universitari Vall d'Hebron, Barcelona, Spain
² Complejo Hospitalario de Navarra, Pamplona, Spain
³ Hospital Universitario de La Princesa, Madrid, Spain
⁴ Hospital Universitario Vall d'Hebron, Barcelona, Spain
⁵ Hospital General Universitario de Alicante, Alicante, Spain
⁶ Hospital Puerta de Hierro Majadahonda, Madrid, Spain
⁷ Hospital Universitario Central de Asturias, Oviedo, Spain
⁸ Hospital Universitario 12 de Octubre, Madrid, Spain
⁹ La Paz University Hospital, Madrid, Spain
¹⁰ Hospital Universitario Son Espases, Palma, Spain
¹¹ Complejo Asistencial Universitario de León, León, Spain
¹² Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain
¹³ Hospital de Sant Pau, Barcelona, Spain
¹⁴ La Fe University and Polytechnic Hospital, Valencia, Spain
¹⁵ Takeda Farmacéutica España S.A., Madrid, Spain
¹⁶ Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)